FDA Inspection 1223321 - InvaGen Pharmaceuticals, Inc. - October 25, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns InvaGen Pharmaceuticals, Inc., with an inspection on October 25, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: InvaGen Pharmaceuticals, Inc.
Inspection Date: October 25, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · ab7f3625-f61f-420c-9396-b2e66e188b6d